Liguo Xie

Mr. Liguo Xie


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LXLiguo Xie
Liguo Xie
XJXiuling Ji
Xiuling Ji
QZQi Zhang
Qi Zhang
WYWei Yunlin
Wei Yunlin
Curcumin, a phytochemical derived from the rhizome of turmeric (Curcuma longa L.), has a broad group of substances with antibacterial, anti-inflammatory, anti-oxidant, anticancer activities. The anticancer activity of curcumin and its derivatives are mainly related to its regulation of signal transduction pathways. However, due to the low oral availability of curcumin, fast metabolism and other pharmacokinetic properties limit the application of curcumin in the treatment of cancer. Evidence suggests that curcumin combined with photodynamic therapy can overcome the limitation of curcumin's low bioavailability by acting on apoptosis pathways, such as B-cell lymphoma 2 (Bcl-2) and caspase family, and affecting cell cycle. This paper reviews the structure and pharmacokinetics of curcumin, focusing on the anticancer activity of curcumin combined with photodynamic therapy and the effects on cancer-related signal pathways.

1 November 2021 in Cellular Signalling
Verified
Journal Article
Closed access
LXLiguo Xie
Liguo Xie
GZGuodong Zhu
Guodong Zhu
JSJunjie Shang
Junjie Shang
XCXuemei Chen
Xuemei Chen
CZChunting Zhang
Chunting Zhang
WYWei Yunlin
Wei Yunlin

3 February 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
LXLiguo Xie
Liguo Xie
LCLifangyu Cheng
Lifangyu Cheng
YWYunlin Wei
Yunlin Wei